Renaissance Capital logo

ASPI News

Renaissance Capital's November IPO Market Update

ACRV

It was the IPO market's slowest November in six years as just four deals raised a combined $166 million. The month's lineup was led by $50+ million IPOs, biotech Acrivon Therapeutics (ACRV) and Chinese hotel chain Atour Lifestyle Holdings (ATAT). Two small issuers also slipped through the IPO window despite increased scrutiny from regulators....read more

US IPO Weekly Recap: Chinese hotel chain leads a 3 IPO week

INTS

Three IPOs and one SPAC began trading this past week, though neither of the scheduled biotechs made it to market as Intensity Therapeutics (INTS) postponed and Acrivon Therapeutics (ACRV) delayed its pricing. One IPO and two SPACs submitted initial filings. In the pipeline, large IPOs KinderCare Learning Companies (KLC),...read more

Isotope enrichment company ASP Isotopes prices further downsized IPO at $4 low end

ASPI

ASP Isotopes, which is developing isotope enrichment facilities for medical and energy applications, raised $5 million by offering 1.3 million shares at $4, the low end of the downwardly revised range of $4 to $5. The company offered 0.3 million fewer shares than anticipated. It originally planned to offer 2.0 million shares at a range of $5 to $7 before lowering the terms...read more

Isotope enrichment company ASP Isotopes cuts deal size by 44% ahead of $7 million IPO

ASPI

ASP Isotopes, which is developing isotope enrichment facilities for medical and energy applications, lowered the proposed deal size for its upcoming IPO on Monday. The Boca Raton, FL-based company now plans to raise $7 million by offering 1.5 million shares at a price range of $4 to $5. The company had previously filed to offer 2 million shares at a range of $5 to $7. At the...read more